3647 results for «590»
3647 results
Improving interventional care and occupational safety
19 May 2026 – From EuroPCR 2026
This session addresses advancements in interventional cardiology care quality and occupational safety. Key topics include patient-centered care perspectives, optimized catheterization lab scheduling, the impact of procedural volumes on outcomes, and innovations in radiation protection technologies.
CTO PCI: technical developments
19 May 2026 – From EuroPCR 2026
This session highlights technical developments in CTO PCI, featuring comparative insights from the ONUBA-CTO study on retrograde versus antegrade approaches, sex-based differences in long-term outcomes, management of balloon-undilatable lesions, the role of virtual reality audiovisual distraction, the impact of core laboratory feedback with OCT, and contemporary...
Beyond valves: expanding the structural toolbox
19 May 2026 – From EuroPCR 2026
This session expands the scope of structural heart interventions beyond valve therapies. It covers embolic protection in high-risk intracardiac procedures, outcomes of paravalvular leak closures, novel aortic root stent-graft research, cerebral ischemia predictors after TEVAR, and transcatheter ASD closure techniques.
Behind standard practice: a place for DCB
19 May 2026 – From EuroPCR 2026
This session examines the role of drug-coated balloons (DCB) beyond standard practice in coronary revascularization. It includes discussions on revascularization strategies in young patients, rescue of early distal LIMA–LAD anastomosis, treatment of in-stent restenosis, stepwise complex CTO bifurcation revascularization using kissing DCBs, and management of calcified...
Top Interventional Trials presented at ACC.21
07 Jun 2021
Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
